{"id":867527,"date":"2025-07-08T12:03:17","date_gmt":"2025-07-08T16:03:17","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/rocket-pharmaceuticals-inc-rckt-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-3\/"},"modified":"2025-07-08T12:03:17","modified_gmt":"2025-07-08T16:03:17","slug":"rocket-pharmaceuticals-inc-rckt-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-3","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/rocket-pharmaceuticals-inc-rckt-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-3\/","title":{"rendered":"Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n
\n LOS ANGELES<\/span>
\n <\/span>, July 8, 2025<\/span><\/span> \/PRNewswire\/ — Glancy Prongay<\/span> & Murray LLP<\/a> announces that investors with losses have opportunity to lead the securities fraud<\/span> class action lawsuit against Rocket Pharmaceuticals, Inc. (“Rocket” or the “Company”) (NASDAQ:\u00a0RCKT<\/a>).<\/p>\n

\n

\n
\n \"Glancy
\n <\/a>\n <\/p>\n<\/p><\/div>\n

\n IF YOU SUFFERED A LOSS ON YOUR ROCKET INVESTMENTS, CLICK\u00a0<\/b>
\n
\n HERE<\/b>
\n <\/a>
\n BEFORE AUGUST 11, 2025<\/span> (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD<\/span> LAWSUIT <\/b>\n <\/p>\n

\n What Is The Lawsuit About?<\/b>
\n
The complaint filed alleges<\/span> that, between February 27, 2025<\/span> and May 26, 2025<\/span>, Defendants failed to disclose to investors that: (1) Rocket knew SAEs, including death of participants enrolled in the study, were a risk; (2) Rocket amended the trial’s protocol to introduce a novel immunomodulatory agent to the pretreatment regimen without providing this critical update to shareholders; and (3) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and\/or lacked a reasonable basis at all relevant times.<\/p>\n

\n Contact Us To Participate or Learn More:\u00a0
<\/b>If you wish to\u202flearn more\u202fabout this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us.
Charles\u00a0Linehan, Esq.,
Glancy Prongay<\/span> & Murray LLP,
1925 Century Park East, Suite 2100,
Los Angeles California<\/span> 90067
Email: \u00a0shareholders@glancylaw.com<\/a>
Telephone: 310-201-9150 (Toll-Free: 888-773-9224)
Visit our website at\u00a0www.glancylaw.com<\/a>.
Follow us for updates on LinkedIn<\/a>, Twitter<\/a>, or Facebook<\/a>.<\/p>\n

If you inquire by email, please include your mailing address, telephone number and number of shares purchased.\u00a0<\/p>\n

To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.<\/p>\n

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.<\/p>\n

\n Contact Us:\u00a0
<\/b>
\n Glancy Prongay<\/span> & Murray LLP, \u00a0
1925 Century Park East, Suite 2100,
Los Angeles, CA<\/span> 90067
Charles Linehan<\/span>
<\/b>Email: \u00a0shareholders@glancylaw.com<\/a>
Telephone: 310-201-9150
Toll-Free: 888-773-9224
Visit our website at:\u00a0www.glancylaw.com<\/a>.<\/p>\n

\n \"Cision\" View original content to download multimedia:https:\/\/www.prnewswire.com\/news-releases\/rocket-pharmaceuticals-inc-rckt-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-302499732.html<\/a><\/p>\n

SOURCE Glancy Prongay<\/span> & Murray LLP<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire LOS ANGELES , July 8, 2025 \/PRNewswire\/ — Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Rocket Pharmaceuticals, Inc. (“Rocket” or the “Company”) (NASDAQ:\u00a0RCKT). IF YOU SUFFERED A LOSS ON YOUR ROCKET INVESTMENTS, CLICK\u00a0 HERE BEFORE AUGUST 11, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About? The complaint filed alleges that, between February 27, 2025 and May 26, 2025, Defendants failed to disclose to investors that: (1) Rocket knew SAEs, including death of participants enrolled in the study, were a risk; (2) Rocket amended the trial’s protocol to introduce a novel immunomodulatory agent to the pretreatment regimen … <\/p>\n

Continue reading “Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-867527","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nRocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/rocket-pharmaceuticals-inc-rckt-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-3\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire LOS ANGELES , July 8, 2025 \/PRNewswire\/ — Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Rocket Pharmaceuticals, Inc. (“Rocket” or the “Company”) (NASDAQ:\u00a0RCKT). IF YOU SUFFERED A LOSS ON YOUR ROCKET INVESTMENTS, CLICK\u00a0 HERE BEFORE AUGUST 11, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About? The complaint filed alleges that, between February 27, 2025 and May 26, 2025, Defendants failed to disclose to investors that: (1) Rocket knew SAEs, including death of participants enrolled in the study, were a risk; (2) Rocket amended the trial’s protocol to introduce a novel immunomodulatory agent to the pretreatment regimen … Continue reading "Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/rocket-pharmaceuticals-inc-rckt-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-3\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-08T16:03:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/2395212\/Glancy_Prongay.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rocket-pharmaceuticals-inc-rckt-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-3\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rocket-pharmaceuticals-inc-rckt-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-3\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit\",\"datePublished\":\"2025-07-08T16:03:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rocket-pharmaceuticals-inc-rckt-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-3\\\/\"},\"wordCount\":362,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rocket-pharmaceuticals-inc-rckt-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2395212\\\/Glancy_Prongay.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rocket-pharmaceuticals-inc-rckt-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-3\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rocket-pharmaceuticals-inc-rckt-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-3\\\/\",\"name\":\"Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rocket-pharmaceuticals-inc-rckt-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-3\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rocket-pharmaceuticals-inc-rckt-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2395212\\\/Glancy_Prongay.jpg\",\"datePublished\":\"2025-07-08T16:03:17+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rocket-pharmaceuticals-inc-rckt-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-3\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rocket-pharmaceuticals-inc-rckt-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-3\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rocket-pharmaceuticals-inc-rckt-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-3\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2395212\\\/Glancy_Prongay.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2395212\\\/Glancy_Prongay.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rocket-pharmaceuticals-inc-rckt-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-3\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/rocket-pharmaceuticals-inc-rckt-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-3\/","og_locale":"en_US","og_type":"article","og_title":"Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Market Newsdesk","og_description":"PR Newswire LOS ANGELES , July 8, 2025 \/PRNewswire\/ — Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Rocket Pharmaceuticals, Inc. (“Rocket” or the “Company”) (NASDAQ:\u00a0RCKT). IF YOU SUFFERED A LOSS ON YOUR ROCKET INVESTMENTS, CLICK\u00a0 HERE BEFORE AUGUST 11, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About? The complaint filed alleges that, between February 27, 2025 and May 26, 2025, Defendants failed to disclose to investors that: (1) Rocket knew SAEs, including death of participants enrolled in the study, were a risk; (2) Rocket amended the trial’s protocol to introduce a novel immunomodulatory agent to the pretreatment regimen … Continue reading \"Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/rocket-pharmaceuticals-inc-rckt-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-3\/","og_site_name":"Market Newsdesk","article_published_time":"2025-07-08T16:03:17+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/2395212\/Glancy_Prongay.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rocket-pharmaceuticals-inc-rckt-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-3\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rocket-pharmaceuticals-inc-rckt-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-3\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit","datePublished":"2025-07-08T16:03:17+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rocket-pharmaceuticals-inc-rckt-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-3\/"},"wordCount":362,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rocket-pharmaceuticals-inc-rckt-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-3\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2395212\/Glancy_Prongay.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rocket-pharmaceuticals-inc-rckt-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-3\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/rocket-pharmaceuticals-inc-rckt-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-3\/","name":"Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rocket-pharmaceuticals-inc-rckt-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-3\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rocket-pharmaceuticals-inc-rckt-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-3\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2395212\/Glancy_Prongay.jpg","datePublished":"2025-07-08T16:03:17+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rocket-pharmaceuticals-inc-rckt-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-3\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/rocket-pharmaceuticals-inc-rckt-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-3\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rocket-pharmaceuticals-inc-rckt-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-3\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/2395212\/Glancy_Prongay.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/2395212\/Glancy_Prongay.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rocket-pharmaceuticals-inc-rckt-investors-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-3\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/867527","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=867527"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/867527\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=867527"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=867527"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=867527"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}